Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced that President David Petty and Chief Financial Officer Jody Phillips will present at the Eighth Annual Noble Financial Equity Conference in Hollywood, Florida on Tuesday, January 17th at 10:00 a.m. EST.
Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopedic implant devices and related surgical instrumentation, as well as provides biologic services to hospitals and physicians in the United States and internationally.
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced that Tessie M. Che, Ph.D., Chief Operating Officer & Senior Vice President, Corporate Affairs, is departing the Company to pursue other interests.
Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing hospital specialty products worldwide. It develops products that treat gastrointestinal infections and related diseases.
Crown Equity Holdings, Inc. (CRWE)
Crown Equity Holdings, Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
Crown Equity Holdings Inc. (CRWE) is recently announced that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.
Commenting on the joint venture, Kenneth Bosket, President of Crown Equity Holdings Inc., said: “We are excited to deliver VoIP communications solutions specifically designed to meet the business and residential market needs in this fast-growing global market.”
VoIP technology also entails greater mobility and flexibility. For small business owners who are always on the go, a VoIP phone system can be of big help. The system has special call routing features that allow business owners to still get in touch with their current and prospective clients and investors wherever they are. And because calls are made over the internet, any device that has speedy broadband connection, including PCs and laptops, PDAs, and palm computers, are suitable for this highly-flexible phone system.
The benefits of using this revolutionary phone system are aplenty and small businesses have endless possibilities as to what they can do if they take advantage of it. And while this technology may indeed seem like a savior for many small businesses, there are still certain considerations that owners need to make.
First important consideration is to ensure the availability of back up source of power in case of power outage. Some, especially those who are a newbie to VoIP technology, might also need to have technical know-how and skills about this phone system; although no training is really necessary as it’s easy to learn how to install, use, and configure the system. There is no need to hire professional installers or VoIP experts.
For more information please visit official website of CRWE: www.crownequityholdings.com
Stereotaxis, Inc. (NASDAQ:STXS) announced the completion of the first 50 clinical procedures using the Company’s new Niobe ES� system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia. Positive initial results with the Niobe ES system in Europe demonstrate that the average time for completion of mapping and ablation for the initial AF patients was 69 minutes.
Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control systems for use in a hospital�s interventional surgical suite or interventional lab for the treatment of arrhythmias and coronary artery diseases in the United States and internationally.
No comments:
Post a Comment